Google Parent and Sanofi Name Diabetes Joint Venture Onduo

Joint venture will research diabetes treatments

Joshua Riff, who was a senior executive at UnitedHealth Group’s Optum, will be CEO of the new unit. PHOTO: EUROPEAN PRESSPHOTO AGENCY

PARIS—French pharmaceutical group Sanofi SA is joining with Verily Life Sciences LLC, a unit of Google parent Alphabet, to create a joint venture called Onduo to research diabetes treatments.

“Onduo’s mission is to help people with diabetes live full, healthy lives by developing comprehensive solutions that combine devices, software, medicine, and professional care to enable simple and intelligent disease management,” Sanofi and Verily, which was previously known as Google Life Science, said.

The two companies appointed Joshua Riff, who was a senior executive at UnitedHealth Group’s Optum, as the chief executive of the new unit.

Sanofi is a leading maker of diabetes medication, as well as many other drugs. Onduo will combine Verily’s experience in miniaturized electronics, analytics, and consumer software development, and Sanofi’s clinical expertise and experience in providing treatment to diabetic people.

Sanofi is seeking new diabetes treatments as revenue from its diabetes drugs in the U.S. fell after its insulin Lantus lost patent protection there.Diabetes is expected to affect 592 million people world-wide by 2035, according to the International Diabetes Federation.

Featured Posts
Recent Posts
Archive
Search By Tags

About Pharmanaming.com and GNN

The Global Naming Network (GNN), headquartered in Geneva, is the world's largest network of independent naming and brand identity agencies.

 

With around 240 cooperating naming and branding specialists in 16  countries, from Beijing to New York and from Seoul to Paris, GNN works for clients ranging from large multinationals to small startups all over the world.

Pharmaceutical projects are coordinated from the GNN office in Amsterdam by the pharma naming specialists of Globrands.

The www.pharmanaming.com website is dedicated to our expertise and work for the health & pharma industry.

 

Please contact us for more information.

20

offices in 16 countries

240

creatives, strategists & consultants

GNN offices

China                     South Korea

France                   Italy
Germany               Japan

Netherlands          UK

India                      Singapore

Spain                     Canada

Switzerland          Russia

USA                       Dubai

5000

projects successfully executed

Pages

home                           name to brand

health & pharma        people

regulatory                   test & submit

India                             FDA

work                             blog

clients                          contact

20000

linguistic professionals worldwide

Globrands the name behind the brands

© 2020 by Globrands consultancy group

Herengracht 122, 1015 BT Amsterdam, the Netherlands

call +31206238555 or mail to pharma@globrands.com  

 

  • White LinkedIn Icon